PMGC Holdings Inc. - SIC # 2840 -

Ticker Exchange SIC # Website Latest Ticker
ELAB Nasdaq 2840 pmgcholdings.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for PMGC Holdings Inc.

PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings - Sep 18th, 2026 6:00 am
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications - Sep 1st, 2026 5:45 am
PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio - Aug 26th, 2026 6:17 am
PMGC Holdings Signs Orbit2Orbit Term Sheet for Microgravity Muscle Research - Aug 25th, 2026 7:46 am
PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss - Aug 25th, 2026 5:30 am
NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight - Aug 21st, 2026 7:30 am
PMGC Holdings Inc. Announces Anticipated Reverse Stock Split - Aug 19th, 2026 9:45 am
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q2 2026 Results and Files Form 10-Q; Total Assets Reach $36.6 Million, Up 184% from Year-End 2025 and 290% Year-over-Year, as Quarterly Revenue Nearly Doubles Sequentially - Aug 14th, 2026 7:31 am
PMGC Holdings Confirms Compliance with Nasdaq’s New $5 Million Market Value of Listed Securities Requirement - Jul 29th, 2026 1:54 pm
PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc. - Jul 28th, 2026 5:30 am
NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to License - Jul 27th, 2026 5:30 am
NorthStrive Defense Tech Executes Definitive Exclusive License Agreement with Florida State University Research Foundation for Multi-Domain Drone Payload Technology Across Defense, Aerospace and Maritime Applications - Jul 13th, 2026 5:30 am
PMGC Holdings Advances EL-22 FACS Analysis to Support Manufacturing Comparability - Jul 10th, 2026 9:00 am
NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression - Jul 10th, 2026 5:30 am
PMGC Holdings Inc. Announces Merger of AGA Precision Systems into A&B Aerospace - Jul 6th, 2026 5:30 am
NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences - Jul 1st, 2026 5:30 am
NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets - Jun 18th, 2026 5:30 am
PMGC Holdings Highlights Advanced Precision Manufacturing Capabilities Supporting Space Exploration Supply Chains - Jun 10th, 2026 5:31 am
NorthStrive Defense Tech Executes Binding Agreement to Acquire Exclusive License to Patented Multi-Domain Drone Payload Technology for Defense, Aerospace and Maritime Applications - Jun 8th, 2026 5:31 am
PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor Markets - Jun 1st, 2026 5:31 am